In the field of Urology, Renauxe Pharma plays a significant role, particularly in addressing prostate ailments such as Benign Prostatic Hyperplasia (BPH), bladder disorders, Gout, Andrology Care medicines, and Urinary stones, to UTI management and adjuvant therapies of Ca prostate. 

Renauxe Pharma takes pride in its urology portfolio, featuring medications such as Silodosin, Mirabegron, Solifenacin, Tamsulosin, Dutasteride, Tadalafil, Sodium bicarbonate, Potassium Magnesium Citrate with Vitamin B6, L Carnitine, and Febuxostat. These formulations are designed to meet the unique needs of urological and Andrology care, Erectilea dysfunction, Ca Prostate, and more.

With a focus on innovation and efficacy, Renauxe Pharma’s Urology portfolio stands as a testament to our dedication to meeting the unique healthcare needs of patients dealing with urological challenges.